Antiplatelet Therapy in Patients With COVID-19
Because venous and arterial thromboembolism are common among patients hospitalized with COVID-19, anticoagulant therapies were among the first to be evaluated i
Source: jamanetwork.com
Stay updated with breaking news from Coagulation Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Because venous and arterial thromboembolism are common among patients hospitalized with COVID-19, anticoagulant therapies were among the first to be evaluated i
Therapeutic levels of heparin can have widely varying effects on COVID-19 patients depending on the severity of their disease, according to a multiplatform clinical trial.